Press release
Targeted Cancer Therapies Market to Witness Widespread Expansion During 2017 - 2025
Targeted cancer therapies market is growing, this is attributed to increasing prevalence of various types of cancers such as lung cancer, breast cancer, colorectal cancer, prostate cancer, lymphoma, leukaemia, melanoma etc. Also increasing awareness regarding molecular diagnostic techniques such as liquid biopsy to detect malignancy is expected to drive the market for targeted cancer therapies over the forecast period. Growing healthcare expenditure, and rising insurance coverage, aids in the revenue growth of targeted cancer therapies market. Increasing number of new targeted anti-cancerous drugs also drives the market for targeted anti-cancer drugs. However higher pricing of these drugs along with higher pricing of the molecular diagnostic tests to detect cancer is expected to hamper the growth of the targeted cancer therapies market over the forecast period.
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/13807
The targeted cancer therapies market is segment based on the therapy type, end user and application
Targeted cancer therapies market is segmented into following types:
By Therapy Type
Hormone Therapies
Signal Transduction Inhibitors
Gene Expression Modulators
Apoptosis Inducers
Angiogenesis Inhibitors
Immunotherapies
Monoclonal Antibodies
By Disease Indication
Gastrointestinal
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Melanoma
Prostate Cancer
Others
By End User
Hospitals
Cancer and Radiation Therapy Centers
Clinics
Targeted cancer therapies market revenue is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well in the near future due to increasing awareness regarding various cancer types and their treatment protocols. Also the targeted cancer therapies market is expected to expand globally due increasing prevalence of cancer and increasing preference of oncologists to prescribe targeted anti-cancer drugs for the patients. The targeted therapies for lung cancer is anticipated to grow with a fastest CAGR over the forecast period, attributed to increasing number of smokers globally. Increasing competition among anti-cancer drug manufacturers, increasing investment in R&D and increasing number of new drug launches are the major factors estimated to drive the revenue growth of targeted cancer therapies market.
Depending on geographic region, the targeted cancer therapies market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific (APAC) and Middle East & Africa (MEA).
North America is occupying the largest regional market share in the global targeted cancer therapies market owing to the presence of more number of market players, high patient awareness levels, increasing healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing activities in the region. Also Europe is expected to perform well in the near future due to increasing inclination of oncologists and physicians in the region prescribing targeted anti-cancerous drugs to the patients suffering from cancer.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/13807
Asia Pacific is expected to grow at the fastest CAGR because of increasing prevalence of different types of cancers in the region, thus boosting the market growth of targeted cancer therapies market throughout the forecast period.
Key players of targeted cancer therapies market includes Abbott Laboratories, Bayer HealthCare AG, GlaxoSmithKline plc, OncoGenex Pharmaceuticals Inc., Hospira Inc., Boehringer Ingelheim GmbH, AstraZeneca, Aveo Pharmaceuticals and many more. The companies in targeted cancer therapies market are increasingly engaged in strategic partnerships, collaborations, mergers and acquisitions to capture a greater pie of market share as the market is in the nascent stage.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted Cancer Therapies Market to Witness Widespread Expansion During 2017 - 2025 here
News-ID: 749707 • Views: …
More Releases from Persistence Market Research
Cold Seal Packaging Market to Hit US$28.5 Bn by 2031, Fueled by Eco-Friendly Dem …
The cold seal packaging market is experiencing rapid growth as industries across the globe shift toward more efficient, cost-effective, and eco-friendly packaging methods. Known for its ability to provide fast, reliable, and high-quality sealing without the use of heat, cold seal packaging has become increasingly popular in food, pharmaceuticals, and consumer goods sectors. Its unique sealing mechanism allows for greater speed in production lines, reduced energy consumption, and enhanced protection…
Gamma Knife Market Booming to US$692 Million by 2032 Driven by Non-Invasive Neur …
The gamma knife market plays a crucial role in the advancement of non-invasive neurosurgical treatments. Gamma knife technology is extensively used for the treatment of brain tumors, vascular malformations, trigeminal neuralgia, and other neurological disorders. By delivering highly precise radiation to targeted areas of the brain while minimizing damage to surrounding healthy tissues, gamma knife systems improve treatment outcomes and reduce recovery times, making them indispensable in modern neurosurgery. According…
Portable Power Station Market to Reach US$ 1.44 Bn by 2032: Growth Driven by Ris …
The global portable power station market is undergoing remarkable expansion, fueled by the rising adoption of clean energy solutions, increased outdoor recreational activities, and a growing need for reliable emergency power backup systems. Portable power stations, often referred to as battery-powered generators, are compact and versatile energy storage devices designed to provide power on the go. Unlike conventional fuel-based generators, they offer a clean, noise-free, and environmentally friendly alternative for…
Polypropylene Market to Reach US$ 128.0 Bn by 2032: Growth Driven by Rising Dema …
The polypropylene market has emerged as one of the most dynamic and versatile segments within the global plastics industry. Known for its lightweight, durability, and chemical resistance, polypropylene (PP) is extensively used across industries such as packaging, automotive, construction, textiles, and healthcare. Its cost-effectiveness and recyclability make it a material of choice in numerous applications, aligning with the growing demand for sustainable and efficient materials.
According to the latest study by…
More Releases for Targeted
Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
• Approved Targeted Alpha Therapy Dosage & Pricing Insight
• Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs
• Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase
• Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication
• Targeted Alpha Therapy Proprietary Technology Platform Insights By…
Dark Truth Behind Targeted Violence
Intimidation and cyberbullying public bullying the (target)victims selected into committing the violent criminal acts if the victims mentality was broken.
The perpetrators are small fraud groups organizing misinformation with false profiles for the public to participate with public bullying while the groups stalk the victim.
San Diego California 2021-2024 plot failed federal agents on standby monitoring the targets failed at there duties of integrity while presidential elections push towards Nov 5 San…
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes.
One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in…
Targeted Email Leads: Pioneering a New Era in Email Marketing with High-Quality, …
GREENSBORO, NC - 15 August 2024 - In the rapidly evolving digital landscape, one company is setting new standards in email marketing. Targeted Email Leads, a trailblazer in the provision of precision-targeted email lists, is offering meticulously cleaned and verified lists that cater to a wide range of applications, from B2B communications to consumer engagement and interest groups.
What sets Targeted Email Leads apart is their rigorous verification process. Each…
Tetravalent Antibody as Cancer Targeted Therapy
The advent of tetravalent antibodies marks a significant breakthrough in cancer targeted therapy, offering a sophisticated approach to tackling the complex and heterogeneous nature of tumors. These antibodies, engineered to bind to four distinct antigens or epitopes simultaneously, provide enhanced specificity and efficacy, addressing the limitations of traditional monoclonal and even bispecific antibodies.
Download Bispecific, Trispecific and Tetraspecific Antibodies Report:
https://www.kuickresearch.com/ccformF.php?t=1721642510
Cancer is a multifaceted disease characterized by diverse cell populations within a…
Targeted Advertising Solutions Market - Rising Demand from the Providers of Targ …
The rising popularity of digital channels such as mobile and online for media and entertainment, and communications, coupled with their capability to identify and benefit from tracking customer behavior accurately, have created major interest and increasing investments by advertisers on targeted advertising.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47862
Organizations making an entry into the advertising value network need to effectively educate, engage, and create alertness to the advantages of targeted…
